Factorial Partners, LLC Organon & Co. Transaction History

Factorial Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$16.59 - $23.77 $149,310 - $213,930	-9,000 Reduced 32.14%	19,000 $329,000
Q2 2023 Aug 02, 2023	SELL	$19.27 - $24.63 $375,765 - $480,285	-19,500 Reduced 41.05%	28,000 $582,000
Q1 2023 May 03, 2023	BUY	$21.42 - $32.08 $10,710 - $16,040	500 Added 1.06%	47,500 $1.12 Million
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $23,310 - $28,610	-1,000 Reduced 2.08%	47,000 $1.31 Million
Q3 2022 Nov 04, 2022	SELL	$23.4 - $34.25 $280,800 - $411,000	-12,000 Reduced 20.0%	48,000 $1.12 Million
Q2 2022 Aug 03, 2022	BUY	$31.66 - $38.9 $6,332 - $7,780	200 Added 0.33%	60,000 $2.03 Million
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $493,290 - $637,632	-16,200 Reduced 21.32%	59,800 $2.09 Million
Q4 2021 Feb 09, 2022	BUY	$28.67 - $37.13 $114,680 - $148,520	4,000 Added 5.56%	76,000 $2.31 Million
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $2.05 Million - $2.74 Million	72,000 New	72,000 $2.18 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Factorial Partners, LLC with notifications on news.